BlackRock Group’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$966K Sell
15,790
-182
-1% -$11.9K ﹤0.01% 2149
2016
Q3
$1.11M Buy
15,972
+4,298
+37% +$284K ﹤0.01% 1979
2016
Q2
$650K Buy
11,674
+6,970
+148% +$420K ﹤0.01% 2162
2016
Q1
$286K Sell
4,704
-1,698
-27% -$100K ﹤0.01% 2454
2015
Q4
$409K Sell
6,402
-3,142
-33% -$204K ﹤0.01% 2279
2015
Q3
$639K Buy
9,544
+4,584
+92% +$324K ﹤0.01% 2102
2015
Q2
$339K Buy
4,960
+2,722
+122% +$173K ﹤0.01% 2406
2015
Q1
$124K Sell
2,238
-876
-28% -$44.9K ﹤0.01% 2611
2014
Q4
$160K Sell
3,114
-158
-5% -$7.76K ﹤0.01% 2574
2014
Q3
$121K Buy
3,272
+404
+14% +$14.6K ﹤0.01% 2554
2014
Q2
$113K Sell
2,868
-13,968
-83% -$518K ﹤0.01% 2576
2014
Q1
$634K Buy
16,836
+1,520
+10% +$53.1K ﹤0.01% 2161
2013
Q4
$579K Buy
15,316
+8,936
+140% +$342K ﹤0.01% 2184
2013
Q3
$278K Buy
6,380
+5,208
+444% +$209K ﹤0.01% 2396
2013
Q2
$42K Buy
+1,172
New +$35.6K ﹤0.01% 2458

Other funds holding USNA

BlackRock Group's USNA Position: Q4 2016 in Review

BlackRock Group reduced its Usana Health Sciences (USNA) stake by 1.1% in Q4 2016, selling an estimated $11.9K and leaving 15,790 shares worth $966K. The position accounts for ﹤0.01% of the portfolio, ranked #2149.

BlackRock Group first reported a position in USNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.11M in Q3 2016. 149 funds tracked by Wall St. Rank hold USNA as of Q4 2016.

  • BlackRock Group held 15,790 shares of Usana Health Sciences worth $966K as of Q4 2016.
  • BlackRock Group sold 182 Usana Health Sciences shares in Q4 2016, an estimated $11.9K.
  • Usana Health Sciences made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2149 holding.
  • BlackRock Group first reported a position in Usana Health Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Usana Health Sciences position peaked at $1.11M in Q3 2016.
  • 149 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.